RYUCX
Price
$16.43
Change
+$0.09 (+0.55%)
Updated
Jan 31 closing price
Net Assets
32.94M
RYUHX
Price
$19.57
Change
+$0.11 (+0.57%)
Updated
Jan 31 closing price
Net Assets
32.94M
Ad is loading...

RYUCX vs RYUHX

Header iconRYUCX vs RYUHX Comparison
Open Charts RYUCX vs RYUHXBanner chart's image
Rydex Inverse S&P 500® Strategy C
Price$16.43
Change+$0.09 (+0.55%)
VolumeN/A
Net Assets32.94M
Rydex Inverse S&P 500® Strategy H
Price$19.57
Change+$0.11 (+0.57%)
VolumeN/A
Net Assets32.94M
RYUCX vs RYUHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYUCX vs. RYUHX commentary
Feb 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYUCX is a Hold and RYUHX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYUCX (32.9M) and RYUHX (32.9M) have equal amount of cash in the bank . RYUCX pays higher dividends than RYUHX: RYUCX (3.88) vs RYUHX (3.32). RYUCX was incepted earlier than RYUHX: RYUCX (24 years) vs RYUHX (10 years). RYUCX (2500) and RYUHX (2500) have matching initial minimum investment requirements. RYUHX (-14.41) and RYUCX (-15.10) have marching annual gain over last year. RYUHX (-52.03) and RYUCX (-53.87) have equivalent 5 years return.
RYUCXRYUHXRYUCX / RYUHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years10 years-
Gain YTD-2.262-2.200103%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRA1000N/A-
Net Assets32.9M32.9M100%
Annual Yield % from dividends3.883.32117%
Returns for 1 year-15.10-14.41105%
Returns for 3 years-21.07-19.17110%
Returns for 5 years-53.87-52.03104%
Returns for 10 years-75.73-73.81103%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUGDF25.151.34
+5.63%
Lundin Gold Inc.
CIHKY28.130.44
+1.59%
China Merchants Bank Co., Ltd.
BZLFY21.480.31
+1.46%
Bunzl plc
MRAAY8.06-0.04
-0.49%
Murata Manufacturing Inc.
PVCT0.11N/A
-3.17%
Provectus Biopharmaceuticals, Inc.